Details for Patent: 8,703,156
✉ Email this page to a colleague
Which drugs does patent 8,703,156 protect, and when does it expire?
Patent 8,703,156 protects FERRIPROX and is included in one NDA.
This patent has twenty-five patent family members in twenty-three countries.
Summary for Patent: 8,703,156
| Title: | Liquid formulation for deferiprone with palatable taste |
| Abstract: | An oral pharmaceutical liquid formulation comprising deferiprone and a taste masking composition, said taste masking composition comprising an effective amount of a sweetener (such as sucralose) per liter of liquid composition, an effective amount of a thickening and suspension aid, (for example hydroxyethylcellulose), per liter of liquid composition, an effective amount of a humectant (such as glycerin) per liter of liquid composition, and an effective amount of at least one flavoring agent, wherein a final form of said taste-masked pharmaceutical has a substantially non-bitter and palatable taste. |
| Inventor(s): | Spino; Michael (Pickering, CA), Hui; Anita (Unionville, CA), Yang; Cihua (Richmond Hill, CA), Kabir; Mohammed N. (Richmond Hill, CA) |
| Assignee: | Apotex Technologies Inc. (Toronto, Ontario, CA) |
| Application Number: | 12/989,127 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 8,703,156
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | FERRIPROX | deferiprone | SOLUTION;ORAL | 208030-002 | Apr 20, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF TREATING TRANSFUSIONAL IRON OVERLOAD | ⤷ Try a Trial | |||
| Chiesi | FERRIPROX | deferiprone | SOLUTION;ORAL | 208030-001 | Sep 9, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | METHOD OF TREATING TRANSFUSIONAL IRON OVERLOAD | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,703,156
| PCT Information | |||
| PCT Filed | April 25, 2008 | PCT Application Number: | PCT/CA2008/000784 |
| PCT Publication Date: | October 29, 2009 | PCT Publication Number: | WO2009/129592 |
International Family Members for US Patent 8,703,156
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2008355464 | ⤷ Try a Trial | |||
| Brazil | PI0822206 | ⤷ Try a Trial | |||
| Canada | 2722393 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
